Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
OPERATING ACTIVITIES    
Net loss $ (23,810,996) $ (25,766,198)
Adjustments to reconcile net loss to net cash used by operating activities:    
Common stock issued for services 818,231 1,754,814
Stock option expense 1,293,932 2,913,626
Change in fair value of contingent consideration 1,185,667
Depreciation 45,072 64,632
Amortization of intangible assets 1,120,617 1,124,644
Gain on settlement of accounts payable (70,757) (710,264)
Loss on sale of property and equipment 1,349  
Changes in operating assets and liabilities    
Prepaid expenses and deposits 657,366 (64,794)
Accounts payable and accrued expenses 654,214 3,511,984
Net Cash Used in Operating Activities (19,290,972) (15,985,889)
INVESTING ACTIVITIES    
Purchase of property and equipment (4,833) (14,510)
Sale of property and equipment 93,285  
Net Cash Provided by (Used in) Investing Activities 88,452 (14,510)
FINANCING ACTIVITIES    
Proceeds from issuance of common stock for cash 19,580,651
Proceeds from warrants exercised for cash 118,801 26,041
Repayments of short-term notes payable (242,737) (176,075)
Net Cash Provided by (Used in) Financing Activities 19,456,715 (150,034)
NET CHANGE IN CASH 254,195 (16,150,433)
CASH AT BEGINNING OF PERIOD 12,546,890 28,697,323
CASH AT END OF PERIOD 12,801,085 12,546,890
CASH PAID FOR:    
Interest 8,617 6,071
NON CASH FINANCING ACTIVITIES:    
Settlement of contingent consideration   3,425,270
Stock cancellation related to employee resignation 2  
Financing of insurance premiums through issuance of short term notes $ 261,326 215,810
Subscription receivable from exercise of warrants   $ 118,801